Vilin Bio Med Share Price | Vilin Bio Med Stock Screener
VILINBIO
Pharmaceuticals
Track Vilin Bio Med share price live with TickJournal's free stock screener.
Analyse VILINBIO share price charts and track historical price performance.
Use the Vilin Bio Med stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Vilin Bio Med Market Cap
₹67.25 Cr.
VILINBIO P/E Ratio (TTM)
33.37
Vilin Bio Med P/B Ratio
2.26
EPS (TTM)
₹1.37
Dividend Yield
-
Debt to Equity
0.20
VILINBIO 52 Week High
-
Vilin Bio Med 52 Week Low
-
Operating Margin
8.00%
Profit Margin
12.50%
VILINBIO Revenue (TTM)
₹8.00
EBITDA
₹2.00
Net Income
₹1.00
Total Assets
₹35.00
Total Equity
₹28.00
Vilin Bio Med Share Price Chart
Screen Vilin Bio Med share price with an interactive chart. Analyse VILINBIO price trends and volatility across different timeframes.
Vilin Bio Med Company Profile - Fundamental Screener
Screen Vilin Bio Med company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for VILINBIO shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0L4V01013
Vilin Bio Med Balance Sheet Screener
Screen VILINBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 35 | 28 | 32 | 18 | 14 | 14 | 14 |
| Current Assets | 27 | 13 | 19 | 8 | 12 | 12 | 12 |
| Fixed Assets | 3 | 1 | 1 | 2 | 2 | 2 | 2 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 28 | 23 | 23 | 11 | 7 | 7 | 7 |
| Share Capital | 15 | 14 | 14 | 10 | 3 | 3 | 3 |
| Reserves & Surplus | 13 | 9 | 9 | 1 | 4 | 4 | 4 |
Vilin Bio Med Income Statement Screener - Profit & Revenue Analysis
Screen Vilin Bio Med income statement and profit fundamentals.
Analyze VILINBIO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Vilin Bio Med share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8 | 42 | 15 | 16 | 12 | 11 | 12 | 17 |
| Expenses | 7 | 39 | 14 | 15 | 10 | 10 | 11 | 16 |
| EBITDA | 2 | 3 | 1 | 1 | 3 | 1 | 1 | 1 |
| Operating Profit % | 8.00% | 8.00% | 5.00% | 5.00% | 21.00% | 7.00% | 7.00% | 5.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| Profit Before Tax | 1 | 3 | 0 | 0 | 2 | 0 | 0 | 0 |
| Tax | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| Net Profit | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| EPS | 2.20 | 1.37 | 0.16 | 0.12 | 1.25 | 0.10 | 0.15 | 0.20 |
Vilin Bio Med Cash Flow Screener - Liquidity Fundamentals
Screen VILINBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 0 | -7 | -2 | 0 | -1 | -2 |
| Investing Activities | -1 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | -5 | 9 | 2 | 0 | 1 | 2 |
| Net Cash Flow | -6 | 2 | 0 | 0 | 0 | 0 |
Vilin Bio Med Shareholding Pattern Screener
See Vilin Bio Med shareholding pattern with promoter, FII, and DII holdings.
Check Vilin Bio Med promoter holding and ownership changes for VILINBIO on TickJournal.
| Item | 2026-May | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Sept | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 56.65% | 59.57% | 63.65% | 63.89% | 63.89% | 63.89% | 64.09% | 64.52% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 33.06% | 30.19% | 33.95% | 33.55% | 33.49% | 34.18% | 34.47% | 33.84% |
| Other Holding | 10.30% | 10.24% | 2.39% | 2.57% | 2.62% | 1.94% | 1.45% | 1.65% |
| Shareholder Count | 400 | 421 | 462 | 476 | 492 | 551 | 581 | 585 |
Vilin Bio Med Share Dividend Screener - Share Yield Analysis
Check Vilin Bio Med dividend history with payout and yield data.
View Vilin Bio Med dividend details including ex-dates and amounts for VILINBIO stock.
Vilin Bio Med Stock Index Membership
See which indices include Vilin Bio Med stock.
Check VILINBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Vilin Bio Med Market Events Screener - Corporate Actions
Get Vilin Bio Med corporate actions including splits, bonuses, and buybacks.
Check Vilin Bio Med stock events that may affect VILINBIO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.24% | ||
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -4.02% |
| 2026-02-09 | 2026-02-09 | Extraordinary General Meeting | NA | 35.85% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -5.85% |
| 2025-05-17 | 2025-05-17 | Quarterly Result Announcement | NA | 4.73% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | -6.15% |
Vilin Bio Med Competitors Screener - Peer Comparison
Screen VILINBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 449,203 | 38.83 | 58,220 | 6.38% | 11,565 | 60.32 |
| Divis Laboratories | 174,068 | 68.00 | 10,560 | 8.73% | 2,520 | 44.73 |
| Torrent Pharmaceuticals | 157,225 | 73.17 | 13,886 | 20.34% | 2,138 | 62.27 |
| Cipla | 117,752 | 30.65 | 29,045 | 2.24% | 3,870 | 69.96 |
| Dr Reddys Laboratories | 112,071 | 27.24 | 33,593 | -0.44% | 3,998 | 66.21 |
| Zydus Life Science | 111,642 | 21.84 | 26,720 | 13.65% | 5,242 | 62.64 |
| Lupin | 109,768 | 20.66 | 27,488 | 19.98% | 5,345 | 68.05 |
| Mankind Pharma | 103,381 | 54.26 | 14,278 | 12.03% | 1,750 | 64.79 |
| Aurobindo Pharma | 89,575 | 26.13 | 33,385 | 3.21% | 3,376 | 69.05 |
| Laurus Labs | 80,579 | 92.10 | 6,868 | 22.01% | 890 | 72.35 |
Vilin Bio Med Company Announcements - News Screener
Screen VILINBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.